Benzinga•10 hours ago
IN8bio Incorporated is a biotech company developing gamma-delta T cell therapies for the treatment of cancers. Its pipeline includes INB-200, a genetically modified autologous gamma-delta T cell candidate in Phase I clinical trials for the treatment of glioblastoma and solid tumors, and INB-100, an allogeneic product candidate, in Phase I clinical trials to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. IN8bio was incorporated in 2016 and is headquartered in New York, NY.
What is In8bio's quote symbol?
What is the 52 week high and low for In8bio (NASDAQ: INAB)?
How much is In8bio stock worth today?
How much is In8bio's stock price per share?
What is In8bio's Market Cap?